Pilot study of baricitinib for active Sjogren's syndrome

被引：25

作者：

Bai, Wei ^{[1
,2
,3
]}

Liu, Huilan ^{[1
,2
,3
]}

Dou, Lei ^{[4
]}

Yang, YunJiao ^{[1
,2
,3
]}

Leng, XiaoMei ^{[1
,2
,3
]}

Li, Mengtao ^{[1
,2
,3
]}

Zhang, Wen ^{[1
,2
,3
]}

Zhao, Yan ^{[1
,2
,3
]}

Zeng, Xiaofeng ^{[1
,2
,3
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China

[2] Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing, Peoples R China

[3] Peking Union Med Coll Hosp PUMCH, Dept Rheumatol & Clin Immunol, Key Lab Rheumatol & Clin Immunol, Minist Educ,State Key Lab Complex Severe & Rare D, Beijing, Peoples R China

[4] Second Peoples Hosp Wuhu, Dept Rheumatol & Immunol, Wuhu, Anhui, Peoples R China

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 07期

关键词：

autoimmune diseases; sjogren's syndrome; therapeutics; PLACEBO;

D O I：

10.1136/annrheumdis-2021-222053

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1050 / 1052

页数：3

共 7 条

[1] Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells [J].

Aota, Keiko ;

Yamanoi, Tomoko ;

Kani, Koichi ;

Ono, Shinji ;

Momota, Yukihiro ;

Azuma, Masayuki .

INFLAMMATION, 2021, 44 (01) :206-216

[2] Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting [J].

d'Alessandro, Miriana ;

Perillo, Felice ;

Refini, Rosa Metella ;

Bergantini, Laura ;

Bellisai, Francesca ;

Selvi, Enrico ;

Cameli, Paolo ;

Manganelli, Stefania ;

Conticini, Edoardo ;

Cantarini, Luca ;

Sestini, Piersante ;

Frediani, Bruno ;

Bargagli, Elena .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 86

[3] Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) [J].

Seror, Raphaele ;

Bootsma, Hendrika ;

Saraux, Alain ;

Bowman, Simon J. ;

Theander, Eike ;

Brun, Johan G. ;

Baron, Gabriel ;

Le Guern, Veronique ;

Devauchelle-Pensec, Valerie ;

Ramos-Casals, Manel ;

Valim, Valeria ;

Doerner, Thomas ;

Tzioufas, Athanasios ;

Gottenberg, Jacques -Eric ;

Laque, Roser Solans ;

Mandl, Thomas ;

Hachulla, Eric ;

Sivils, Kathy L. ;

Ng, Wan-Fai ;

Fauchais, Anne-Laure ;

Bombardieri, Stefano ;

Priori, Roberta ;

Bartoloni, Elena ;

Goeb, Vincent ;

Praprotnik, Sonja ;

Sumida, Takayuki ;

Nishiyama, Sumusu ;

Caporali, Roberto ;

Kruize, Aike A. ;

Vollenweider, Cristina ;

Ravaud, Philippe ;

Meiners, Petra ;

Brito-Zeron, Pilar ;

Vitali, Claudio ;

Mariette, Xavier .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (02) :382-389

[4]

Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]

[5] Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis [J].

Taylor, Peter C. ;

Keystone, Edward C. ;

van der Heijde, Desiree ;

Weinblatt, Michael E. ;

del Carmen Morales, Liliana ;

Reyes Gonzaga, Jaime ;

Yakushin, Sergey ;

Ishii, Taeko ;

Emoto, Kahaku ;

Beattie, Scott ;

Arora, Vipin ;

Gaich, Carol ;

Rooney, Terence ;

Schlichting, Douglas ;

Macias, William L. ;

de Bono, Stephanie ;

Tanaka, Yoshiya .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :652-662

[6] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial [J].

Wallace, Daniel J. ;

Furie, Richard A. ;

Tanaka, Yoshiya ;

Kalunian, Kenneth C. ;

Mosca, Marta ;

Petri, Michelle A. ;

Doerner, Thomas ;

Cardiel, Mario H. ;

Bruce, Ian N. ;

Gomez, Elisa ;

Carmack, Tara ;

DeLozier, Amy M. ;

Janes, Jonathan M. ;

Linnik, Matthew D. ;

de Bono, Stephanie ;

Silk, Maria E. ;

Hoffman, Robert W. .

LANCET, 2018, 392 (10143) :222-231

[7] JAK Inhibitors: Prospects in Connective Tissue Diseases [J].

You, Hanxiao ;

Xu, Dong ;

Zhao, Jiuliang ;

Li, Jing ;

Wang, Qian ;

Tian, Xinping ;

Li, Mengtao ;

Zeng, Xiaofeng .

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (03) :334-351

← 1 →